Meridian Melancarkan Polimerase Fideliti Tinggi Baharu untuk Menawarkan Penguatan Kukuh untuk Aplikasi NGS dan PCR
CINCINNATI, Jan. 24, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) hari ini mengumumkan Campuran HS Pfu Spesifikasi Tinggi yang bukan sahaja menyediakan penguatan fideliti tinggi, tetapi turut menawarkan penguatan untuk diagnostik seiring (CDx) dan ujian klinikal. Penguatan fideliti tinggi adalah penting untuk aplikasi yang hasilnya bergantung kepada jujukan DNA yang betul, seperti penjujukan […]
Meridian Launched a New High-Fidelity Polymerase to Offer Robust Amplification for NGS and PCR Applications
CINCINNATI, Jan. 23, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced the launch of a High-Specificity Pfu HS Mix that not only provides high-fidelity amplification, but also offers market-leading amplification for companion diagnostic (CDx) and clinical testing. High-fidelity amplification is essential for applications whose outcome depends upon the correct DNA sequence, such […]
Meridian Bioscience to Hold First Quarter 2020 Financial Results Conference Call on February 7, 2020
CINCINNATI, Jan. 15, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report first quarter 2020 financial results Friday, February 7, 2020. Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call beginning […]